Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine- associated thrombotic thrombocytopenic purpura

Annals of Internal Medicine

Volumn 132, Issue 10, 2000, Pages 794-799

  Tsai, Han Mou ^a   Rice, Lawrence ^b   Sarode, Ravindra ^c   Chow, Thomas W ^d   Moake, Joel L ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; METALLOPROTEINASE; TICLOPIDINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0034674030     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-10-200005160-00005     Document Type: Article

References (19)

1. Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 1998;129:394-405.
2. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet. 1991;337:774-6.
3. Bennett CL, Weinberg, PD, Rozenberg-Ben-Dror K, Yarnold PR, KwaanHC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998;128:541-4.
4. Bennett CL, Kiss JE, Weinbert PD, Pinevich AJ, Green D, Kwaan HC, et al. Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet. 1998;352:1036-7.
5. Steinhubl SR, Tan WA, Foody JM, Topol EJ. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. JAMA. 1999;281:806-10.
6. Moschcowitz E. Hyalin thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease. Proceedings of the New York Pathology Society. 1924;24:21-4.
7. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al. Unusually large plasma factor VIII:von Willebrand factor multimers in hronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982; 307:1432-5.
8. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med. 1989;87:9N-15N.
9. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K. Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res. 1985;38: 469-79.
10. Chow TW, Turner NA, Chintagumpala M, McPherson PD, Nolasco LH, Rice L, et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol. 1998;57:293-302.
11. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87: 4235-44.
12. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A. 1990;87:6306-10.
13. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996;88:2939-50.
14. Tsai HM. Shear stress enhances the adhesive activity of large von Willebrand factor multimers [Abstract]. Blood. 1996;88:326a.
15. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339:1578-84.
16. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998,339:1585-94.
17. Bennett CL, Davidons C, Raisch DW, Weinberg PD, Bennett RH, Feldman MD. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med. 1999;159:2524-8.
18. Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM. Incidence of a positive direct Coombs test in patients on alpha-methyldopa. Lancet. 1966; 2:133-5.
19. A randomized, blinded trial of clopidogrel versus aspirin in patients at high risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348:1329-39.